newsfilter
← Interviews
a16z27 min

Shifting Risk Mindsets, from Tech to Bio

Jorge Conde, Vijay Pande, Jeff Low, Jeffrey Lowe

Fireside Chat, Interview

Bio-hybrid startups face critical challenges in translating novel technologies to traditional biological partners and avoiding the "death by a thousand pilots" trap through strategic deal structures. Founders must carefully position their platforms to capture value in high-impact areas like Phase III failure prediction while isolating asset risks via legal separation to prevent resource drain. Successful execution requires a hybrid approach to funding and partnership, where founders bridge the linguistic gap between tech and bio communities to align reimbursement models with long-term investor expectations.